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PPARγSerine/threonine protein phosphatase 2A (PP2A) regulates several physiological processes such as the cell cycle,
cell growth, apoptosis, and signal transduction. In this study, we examined the expression and role of PP2A Cα in
adipocyte differentiation. PP2A Cα expression and PP2A activity decreased during adipocyte differentiation in
C3H10T1/2 and 3T3-L1 cells and the expression of adipocyte marker genes such as PPARγ and adiponectin in-
creased. To further clarify the role of PP2A Cα in adipocyte differentiation, we constructed PP2A knockdown
cells by infecting C3H10T1/2 cells with a lentivirus expressing a shRNA speciﬁc for the PP2A Cα (shPP2A cells).
Silencing of PP2A Cα in C3H10T1/2 cells dramatically stimulated adipocyte differentiation and lipid accumula-
tion, which were accompanied by expression of adipocyte marker genes. Silencing of PP2A Cα suppressed
Wnt10b expression and reduced the levels of the inactivated form of GSK-3β (phospho-GSK-3β), leading to
the reduction of β-catenin levels in the nucleus and its transcriptional activity. Treatment with LiCl, a GSK-3β
inhibitor, and inhibition of PPARγ expression suppressed the accelerated adipogenesis of shPP2A cells. Our
data indicate that PP2A Cα plays an important role in the regulation of adipocyte differentiation by regulating
the Wnt/GSK-3β/β-catenin pathway and PPARγ expression.
© 2014 Published by Elsevier B.V.1. Introduction
Protein phosphatases regulate many key cellular processes, in-
cluding glycogen metabolism, the cell cycle, and protein synthesis.
Serine/threonine phosphatases were initially divided into two classes
based on biochemical parameters: type 1 phosphatases (PP1) and
type 2 phosphatases (PP2) [1,2]. Furthermore, PP2 comprises three en-
zymes (PP2A, PP2B, and PP2C) that can be distinguished by their cation
requirements [1,2]. PP2A refers to a large family of heterotrimeric phos-
phatases found in eukaryotic cells [3] and PP2A consists of a structural A
subunit, a regulatory B subunit, and a catalytic C subunit [4,5]. The com-
binatorial assembly of A, B, and C subunits permits the formation of
many distinct PP2A complexes, which have been implicated in the con-
trol of a diverse array of cellular processes, including cell proliferation,
survival, adhesion, and cytoskeletal dynamics [4,5]. The catalytic C sub-
unit comes in two isoforms, Cα and Cβ. PP2ACα knockoutmice showed
embryonic lethality with no mesoderm induction [6–8], which impliesfrom the Ministry of Education
Promotion of Medical Sciences
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ura).that PP2A Cα plays an important role in mesenchymal cells such as
osteoblasts, adipocytes, and myoblasts.
The hormone-stimulated conversion of mouse mesenchymal stem
cells into adipocytes has been extensively studied as a means of identi-
fying the key regulatory factors involved in adipocyte differentiation.
This adipocyte commitment, differentiation, and function are all
governed by several transcription factors that control the expression
of the speciﬁc genes and the acquisition of adipocyte function. Peroxi-
some proliferator-activated receptor γ (PPARγ) is thought to be a
master regulator of adipogenesis [9,10]. PPARγ directly mediates the
increase of CCAAT/enhancer binding protein α (C/EBPα) expression
in the early phase of adipogenic induction [11,12]. Fatty acid-binding
protein 4 (FABP4) is a cytoplasmic fatty-acid binding protein that
plays an important role in fatty acid trafﬁcking in adipocytes [13].
PPARγ and C/EBPα contribute to adipose tissue-speciﬁc expression of
FABP4 [14]. Adiponectin is an adipokine, speciﬁcally secreted by adipo-
cytes, which controls adipocyte differentiation [15,16]. However, little
has been reported on the role of PP2A Cα in adipogenesis and its effects
on the expression of adipocyte marker genes.
The Wnt/β-catenin signaling pathway plays important regulatory
roles in the growth and differentiation of mesenchymal stem cells
[17,18]. In the absence of Wnt ligands, cytoplasmic β-catenin protein
is constantly phosphorylated and degraded by a destruction complex
composed of glycogen synthase kinase 3β (GSK-3β) and Axin [18,19].
Conversely, the binding of Wnt ligands to the cell surface receptors
Fig. 1. PP2A Cα protein expression decreased in C3H10T1/2 cells during adipogenesis. C3H10T1/2 cells were induced to differentiate into adipocytes and adipogenesis was assayed by
Oil red O staining on day 0, 3, 5, and 7 post-induction (A). Bar indicates 20 μm. Total protein was extracted at the indicated time points and the protein expression of the PP2A Cα-, B-,
and A-subunits and Gapdh were analyzed by Western blot (B).
Fig. 2.PP2ACαmRNAexpression decreased in C3H10T1/2 cells during adipogenesis. C3H10T1/2 cellswere induced to differentiate into adipocytes. Total RNAwas isolated at the indicated
time points and the mRNA expression of PP2A Cα, PPARγ, C/EBPα, FABP4, and adiponectin was analyzed by real-time PCR and normalized to Gapdh. Data are expressed relative to the
expression at day 0 as mean ± SD of three independent experiments. Statistically signiﬁcant differences compared with transcript levels at day 0 are indicated by asterisks (**p b 0.01).
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ylate β-catenin. Thus, once β-catenin is stabilized via Wnt signaling, it
translocates to the nucleus where it binds to the T-cell factor (TCF)/
lymphoid-enhancer factor family of transcription factors to regulate
the expression of Wnt target genes [20]. Wnt/β-catenin signaling stim-
ulates osteoblastogenesis of mesenchymal stem cells at the expense of
adipogenesis by suppressing PPARγ and C/EBPα [21,22]. Nineteen Wnt
ligands have been found in humans andmice; one of these, Wnt10b is a
major Wnt ligand in preadipocytes and its levels decline rapidly after
the induction of adipocyte differentiation [23,24]. It was reported that
the overexpression of Wnt10b stabilizes β-catenin and blocks adipo-
genesis [25]. Moreover, Wnt10b inhibits adipogenesis and stimulates
osteoblastogenesis through a β-catenin-dependent mechanism [26].
In the present study, we examined whether PP2A Cαmight be in-
volved in adipogenesis by regulating the expression of adipocyte-
related genes and Wnt10b/GSK-3β/β-catenin pathway. PP2A Cα
expression was reduced in C3H10T1/2 mouse mesenchymal stem cells
and pre-adipocyte 3T3-L1 cells cultured in the adipocyte differentiation
medium. Reduction of PP2A Cα expression dramatically stimulated
adipocyte differentiation through increased expression of adipocyte
marker genes. Silencing of PP2A Cα also attenuatedWnt10b expression
and the phosphorylation of GSK-3β. Furthermore, total and nuclear
β-catenin expression levels and transcriptional activity were reduced
in PP2A Cα-knockdown cells. Treatment with a GSK-3β inhibitor and
the inhibition of PPARγ expression by siRNA suppressed adipogenesis
in shPP2A cells. These ﬁndings indicate that PP2A Cα plays important
roles in the regulation of adipocyte differentiation by regulating the
expression of adipocyte marker genes and the Wnt/GSK-3β/β-catenin
pathway.Fig. 3. PP2A CαmRNA expression decreased in 3T3-L1 cells during adipogenesis. 3T3-L1 cells w
points and themRNA expression of PP2ACα, PPARγ, C/EBPα, and FABP4was analyzed by real-t
mean ± SD of three independent experiments. Statistically signiﬁcant differences compared w2. Materials and methods
2.1. Materials
Alpha- and Dulbecco's-modiﬁed Eagle's minimal essential medium
(α-MEM and DMEM, respectively) was purchased from Invitrogen
(Carlsbad, CA, USA). Plastic dishes were from IWAKI (Chiba, Japan);
and fetal bovine serum (FBS) from JRH Biosciences (Lenexa, KS, USA).
Anti Gapdh and β-actin antibodies, ascorbic acid, β-glycerophosphate,
Fast Red TR, naphthol AS-MX phosphate, recombinant human insulin,
3-isobutyl-1-methylxanthine, dexamethasone, and Oil red O were
purchased from Sigma–Aldrich (St. Louis, MO, USA). Anti PP2A, PP2B,
PP2AC, GSK-3β, and phospho-GSK-3β antibodies were obtained from
Cell Signaling (Danvers, MA, USA). Anti-β-catenin antibody was ob-
tained from R&D Systems (Minneapolis, MN, USA). Anti-Eps antibody
was from Santa Cruz Biotech (Santa Cruz, CA, USA). Anti-H3 antibody
was from Takara Bio (Kyoto, Japan). Okadaic acid (OA) was purchased
from Wako (Osaka, Japan). Other materials used were of the highest
grade commercially available.
2.1.1. Cell culture and differentiation
Mouse mesenchymal stem C3H10T1/2 cells and preadipocyte
3T3-L1 cells were obtained from Riken Cell Bank (Tsukuba, Japan) and
cultured in DMEM and α-MEM, respectively, supplemented with 10%
fetal bovine serum (FBS) at 37 °C under a humidiﬁed atmosphere
of 5% CO2. For induction of adipocyte differentiation, the cells were
exposed to growth medium containing the mixture of insulin, dexa-
methasone, and 3-isobutyl-1-methylxanthine (IDM: 10 μg/ml insulin,
1 μM dexamethasone, and 0.5 mM 3-isobutyl-1-methylxanthine).ere induced to differentiate into adipocytes. Total RNA was isolated at the indicated time
ime PCR and normalized to Gapdh. Data are expressed relative to the expression at day 0 as
ith transcript levels at day 0 are indicated by asterisks (**p b 0.01).
Fig. 4. PP2A activity decreased during adipogenesis. Cell lysates were collected from
C3H10T1/2 cultured in the adipocyte differentiation medium for the indicated periods
and PP2A activity was measured in triplicate. Data are expressed relative to the activity
at 0 day as mean ± SD of representative analysis from three separate experiments
(*p b 0.05; **p b 0.01).
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insulin (10 μg/ml), and this medium was then replenished every other
day. Phase-contrast microphotographs were taken as digital images by
Nikon DS-L2 camera control unit.
2.1.2. RNA preparation and real-time PCR analysis
Total RNA was extracted by the Trizol method as recommended by
the manufacturer (Invitrogen). Real-time PCR of each gene was per-
formed in triplicate for at least three independent experiments with a
7300 Real-time PCR system (Applied Bio-systems, Carlsbad, CA, USA)
using SYBR Premix Ex TaqTM (Takara Bio). The sequences of primers
were as follows: mouse Gapdh (NM_008084) (forward; 761) 5′-TGTG
TCCGTCGTGGATCTGA-3′, (reverse;910) 5′-TTGCTGTTGAAGTCGCAG
GAG-3′; mouse PP2A Cα (NM_019411) (forward; 769) 5′-GCACTCGA
TCGCCTACAGGAA-3′, (reverse; 833) 5′-GGATCTGACCACAGCAAGTC
ACA-3′; mouse PPARγ (NM_001127330) (forward; 1309) 5′-GGAGCC
TAAGTTTGAGTTTGCTGTG-3′, (reverse; 1461) 5′-TGCAGCAGGTTGTCTT
GGATG-3′; mouse C/EBPα (NM_007678) (forward; 2035) 5′-TTGAAG
CACAATCGATCCATCC- 3′, (reverse; 2168) 5′-GCACACTGCCATTGCACA
AG-3′; mouse FABP4 (NM_024406) (forward; 82) 5′-TGGGAACCTGGAFig. 5. Establishment of PP2A Cα-knockdown C3H10T1/2 cells. (A), C3H10T1/2 cells were tran
PP2A Cα shRNA, and then the stable cell lines were constructed. Cells were harvested and lyse
for PP2A Cα and Gapdh. (B), Total RNA was extracted from shCont and shPP2A cells and PP2A
expression in the shCont cells as mean ± SD of representative analysis from three separate exAGCTTGTCTC-3′, (reverse; 278) 5′-GAATTCCACGCCCAGTTTGA-3′; and
mouse adiponectin (NM_009605) (forward; 65) 5′-TTCTGTCTGTACGA
TTGTCAGTGGA-3′, (reverse; 165) 5′-GGCATGACTGGGCAGGATTA-3′.
2.1.3. SDS-PAGE and Western blot analysis
Cells were washed twice with phosphate buffered saline (PBS) and
then scraped into lysate buffer (1 mM DTT, 1 mM PMSF, 1 μg/ml
leupeptin, 2 μg/mL aprotinin, 5 mM EGTA). The protein concentration
was determined by using the Protein Assay Reagent (Bio-Rad, Hercules,
CA, USA) and diluted to a concentration of 1 mg/ml with lysate buffer.
Twelve micrograms of each sample and pre-stained molecular weight
markers were separated by SDS-PAGE and transferred to PVDF mem-
branes (Millipore, Medford, MA, USA). The membranes were incubated
for 2 h at ambient temperature in blocking solution consisting of 5%
non-fat skim milk in PBS containing 0.05% Tween-20 (PBS-Tween),
washed brieﬂy in PBS-Tween, and then incubated overnight at 4 °C in
blocking solution containing speciﬁc antibodies (diluted at 1:1000).
After the membranes had been washed 4 times within 30 min in
PBS-Tween, they were incubated for 2 h at ambient temperature in
blocking solution containing horseradish peroxidase-conjugated second-
ary antibodies (diluted at 1:5000). The membranes were then washed
again as described above, and the proteins recognized by the antibodies
were visualizedwith an ECL detection kit (AmershamPharmacia Biotech,
Uppsala, Sweden) according to the manufacturer's directions.
2.1.4. Serine/threonine protein phosphatase activity assays
The activity of serine/threonine phosphatase was determined by
using a nonradioactive molybdate dye-based phosphatase assay kit
(Promega, Madison, WI, USA) according to the manufacturer's recom-
mendations. Cell lysates were collected in phosphate storage buffer
(50 mM Tris–Hcl, pH 7.0, 0.1 mM EDTA, 1 mM DTT, 0.1% Triton-X,
0.1% benzamide, 0.1% leupeptin) and prepared in PP2A buffer (50 mM
imidazole, pH 7.2, 0.2 mM EGTA, 0.02% β-mercaptoethanol, and
0.1 mg/ml bovine serumalbumin). The cell lysateswereﬂowed through
the Sephadex® G-25 resin to remove extra endogenous phosphate.
Serine/threonine phosphatase activity in these lysates was determined
bymeasuring in triplicate the ability of each cell lysate to dephosphory-
late a synthetic phosphothreonine peptide, RRA[pT]VA, a preferential
substrate of PP2A. The enzyme reaction was started by adding lysates
in 35 μl of phosphate-free water, and the mixture was allowed to incu-
bate for 30 min at room temperature. The reaction was stopped by
the addition of 50 μl molybdate dye-additive mixture, and color was
developed by incubating the mixture for 5 min at room temperature.sfected with shRNA lentivirus particles expressing either a non-target control shRNA or a
d to extract protein, and then the lysate was used inWestern blot with speciﬁc antibodies
CαmRNA expression was determined by real-time PCR. Data are expressed relative to the
periments (**p b 0.01).
Fig. 6.Reduction of PP2A stimulated adipogenesis. shCont and shPP2A cells were induced to differentiate into adipocytes. (A), Adipogenesis was assessed byOil red O staining at day 0 and
day 7 post induction. Bar indicates 20 μm. (B), the triglyceride content of the cells wasmeasured at day 7 after induction of adipogenesis. Data are expressed relative to the values in shCont
cells as mean ± SD of representative analysis from three separate experiments (**p b 0.01).
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tions ranging from 0 to 2000 pmol. Absorbance at 630 nm was mea-
sured by an iMark Absorbance Reader (Bio-Rad) and the amount of
phosphate released was then calculated using the standard curve.2.1.5. Gene silencing
C3H10T1/2 cells were plated at a density of 1 × 104 cells in 96-well
plates. MISSION® shRNA lentiviral transduction particles for PP2A Cα
(NM_019411, Sigma–Aldrich) were infected into the cells according to
the manufacturer's directions and selected stable clones via puromycin
(5 μg/ml) treatment. MISSION® Non-Target shRNA lentiviral transduc-
tion particles were used as negative control. For transient silencing
of PPARγ, C3H10T1/2 cells were transfected with stealth siRNA
targeting PPARγ (Invitrogen, Cat#MSS207863) with Lipofectamine
2000 (Invitrogen) according to the manufacturer's direction.2.1.6. Oil red O staining and quantiﬁcation of triglyceride content
Cells were ﬁxed with 10% formalin for 10 min, washed with PBS,
and incubated for 15 min at room temperature with 0.3% Oil red O
in isopropanol. The stained cells were washed with PBS and then
photographed. In triglyceride measurement, cells were washed with
PBS, and then lysedwith PBS containing 0.5% TritonX-100. After incuba-
tion at 80 °C for 5 min, the lysates were centrifuged, and the amounts
of triglyceride in the supernatants were measured according to the
manufacturer's instruction using a LabAssay Triglyceride Kit (Wako
PureChemical, Osaka, Japan). Triglyceride content is expressed as milli-
grams of triglyceride per milligrams of protein.2.1.7. Luciferase assay
For monitoring of β-catenin transcriptional activity, C3H10T1/2 cells
were transfectedwith a TCF/LEF reporter construct (TOPﬂash,Millipore)
andpTK-Renilla (Promega). Luciferase activitywasmeasured by dual lu-
ciferase assay system (Promega) and normalized to the activity of the
control (pTK-Renilla). The data were obtained from three independent
experiments.Fig. 7. Knockdown of PP2A increased the expression of adipocyte marker genes. shCont
and shPP2A cells were induced to differentiate into adipocytes. Total RNA was isolated
and the mRNA expression of PPARγ, C/EBPα, and FABP4 was analyzed by real-time PCR
and normalized to Gapdh. Data are expressed relative to the expression at day 0 as
mean ± SD of three independent experiments. Statistically signiﬁcant differences
compared to transcript levels at day 0 are indicated by asterisks (**p b 0.01).2.1.8. Statistical analysis
All data were expressed as means ± SD and a minimum of three
independent experiments were performed for each assay. Analysis of
variance (ANOVA) was used for statistical analysis. Statistical signiﬁ-
cance was indicated with “*” (p value b 0.05) or “**” (p value b 0.01).3. Results
3.1. Downregulation of PP2A Cα during adipogenesis
Exposure of C3H10T1/2 mesenchymal stem cells to IDM induced
their differentiation into adipocytes, as revealed by lipid accumulation
(Fig. 1A). Western blot analysis showed that the expression of PP2A
2381H. Okamura et al. / Biochimica et Biophysica Acta 1843 (2014) 2376–2384Cαwas reduced after the induction of adipocyte differentiation, where-
as the expression of the PP2A A and B subunits did not change (Fig. 1B).
In accordance with these results, IDM treatment increased the expres-
sion of adipocyte marker genes in C3H10T1/2 cells, whereas PP2A Cα
mRNA expression was inversely decreased during adipocyte differenti-
ation (Fig. 2). Decreased PP2A Cα expression was also observed in 3T3-
L1 cells after treatment with the adipocyte differentiation medium, as
determined by real-time PCR (Fig. 3). In contrast, adipocyte differentia-
tion marker genes such as PPARγ and C/EBPα were increased in these
cells (Fig. 3). We collected cell lysates from C3H10T1/2 cells cultured
in adipocyte differentiationmedium for and thenmeasured PP2A phos-
phatase activity. PP2A activity decreased in these cells during adipocyte
differentiation (Fig. 4). These results suggest that PP2A Cα is involved in
adipocyte differentiation.
3.2. Silencing of PP2A Cα accelerated adipocyte differentiation
To further clarify the role of PP2A Cα in adipocyte differentiation, we
established PP2A Cα knockdown cells by infecting C3H10T1/2 cells with
a lentivirus expressing a shRNA speciﬁc for PP2A Cα (shPP2A cells).
Fig. 5A shows that shPP2A cells express lower levels of PP2A Cα protein
compared with that in the C3H10T1/2 cells infected with a lentivirus for
non-target control shRNA (shCont cells), as determined byWestern blot.
In agreement with this result, PP2A mRNA expression was signiﬁcantly
lower in shPP2A cells than that in shCont cells (Fig. 5B).We investigated
the ability of adipocyte differentiation of representative shCont and
shPP2A cells. After the cells were cultured in the adipocyte differentia-
tion medium for 7 days, we performed Oil red O staining and observed
the cells under a phase-contrast microscope. Compared with shCont
cells, shPP2A cells showed greater adipocyte differentiation, as re-
vealed by their lipid accumulation (Fig. 6A) and triglyceride content
(Fig. 6B) after the adipogenesis induction. To investigate the molecular
mechanism induced by PP2A Cα silencing, total RNA was extractedFig. 8. The Wnt10b/GSK-3β/β-catenin pathway is involved in the accelerated adipogenesis in
by real-time PCR and normalized to Gapdh. (B), shCont and shPP2A cells were transfected
activity was measured. Data are expressed relative to the value of sample from the shCont c
(**p b 0.01). (C), shCont and shPP2A cells were induced to differentiate into adipocytes. T
β-catenin, and β-actin were analyzed by Western blot. (D), Nuclear and cytoplasmic cell f
formed using the indicated antibodies as indicated. The purity of the cytoplasmic and nuclfrom shCont and shPP2A cells and real-time RT-PCR was performed for
severalmarkers of adipocyte differentiation. The expression of adipocyte
marker genes such as PPARγ, C/EBPα, adiponectin, and FABP4 was
signiﬁcantly higher in shPP2A cells than that in shCont cells (Fig. 7).
3.3. Suppression of the Wnt/β-catenin pathway in shPP2A cells
We examined the involvement of the Wnt/GSK-3β/β-catenin path-
way in the accelerated adipogenesis of shPP2A cells. Wnt10b was
markedly lower in shPP2A cells compared with that in shCont cells
(Fig. 8A). The transcriptional activity of β-catenin was tested in lucifer-
ase reporter assay using a TOP-ﬂash construct carrying β-catenin-
responsive TCF/LEF element. Luciferase activity in shPP2A cells was
signiﬁcantly lower than that in shCont cells (Fig. 8B). To examine the
expression of GSK-3β and β-catenin in shCont and shPP2A cells, we ex-
tracted proteins from these cells and performed Western blot analysis
using speciﬁc antibodies. Western blot analysis showed that the levels
of phosphorylated GSK-3β (inactive form) and total amount β-catenin
were lower in shPP2A cells compared with that in shCont cells (Fig. 8C).
The nuclear localization of β-catenin was further conﬁrmed by cell frac-
tionation. Increased β-catenin expression was detected in the nuclear
fraction in shCont cells, but not in shPP2A cells (Fig. 8D). These results
suggest that, compared with shCont cells, shPP2A cells have higher levels
of active GSK-3β, which degrades β-catenin.
3.4. Inhibition of GSK-3β activity and PPARγ expression suppressed
adipogenesis in shPP2A cells
To examine the role of GSK-3β in the accelerated adipogenesis ob-
served in shPP2A cells, these cells were treated with LiCl, an inhibitor
of GSK-3β. The treated cells were stainedwith Oil red O to assess adipo-
genesis, and triglyceride contentwasmeasured (Fig. 9A and B). Both Oil
redO staining and triglyceride contentwere lower in 10nMLiCl-treatedshPP2A cells. (A), Total RNA was isolated and Wnt10b mRNA expression was analyzed
with Topﬂash vector for 24 h. The cell lysates were collected and then the luciferase
ells transfected with empty vector (pGL3) as mean ± SD of three separate experiments
otal protein was extracted and the expression of phospho-GSK-3β (p-GSK), GSK-3β,
ractions were prepared from shCont and shPP2A cells. Western blot analysis was per-
ear fractions was conﬁrmed by the presence of Eps15 and Histone H3, respectively.
Fig. 9. Inhibition of GSK-3β activity suppressed adipogenesis in shPP2A cells. shPP2A cells were cultured in the adipocyte differentiationmediumwith orwithout 10 nMLiCl. Adipogenesis
was assessed by Oil red O staining (A) and triglyceride content was measured (B) at day 7 post induction. Bar indicates 20 μm. Data are expressed relative to the values in shCont cells as
mean±SDof representative analysis from three separate experiments (**p b 0.01). (C), Total RNAwas isolated and themRNA expression of adipocytemarker geneswas analyzed by real-
time PCR and normalized to Gapdh. Data are mean ± SD of representative analysis from three separate experiments (**p b 0.01).
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extracted from 10 nM LiCl-treated and untreated cells, and real-time
PCR was performed for several markers of adipocyte differentiation.
LiCl treatment decreased the expression of adipocyte marker genes,
including PPARγ and C/EBPα, in shPP2A cells (Fig. 9C). To examine
whether upregulation of PPARγ by PP2A Cα silencing had an effect on
the accelerated adipogenesis, we performed a siRNA-mediated knock-
down experiment for PPARγ in shPP2A cells. The PPARγ knockdown
cells were stained with Oil red O to assess adipogenesis and triglyceride
content was measured (Fig. 10A and B). Compared with the control
cells, PPARγ siRNA suppressed adipogenesis and decreased triglyceride
content. In agreement with these results, PPARγ siRNA decreased the
expression of marker genes, including C/EBPα and adiponectin in
these cells (Fig. 10C).
4. Discussion
In this study, we provided evidence that PP2A Cα is an important
regulator of adipocyte differentiation that functions by regulating
the expression of adipocyte marker genes and the Wnt10b/GSK-3β/
β-catenin pathway. PP2A Cα and PP2A activity decreased during ad-
ipogenesis and reduction of PP2A Cα expression accelerated adipo-
genesis through upregulation of adipocyte differentiation markers.
The Wnt10b/GSK-3β/β-catenin pathway was involved in PP2A Cα-
controlled adipogenesis.
We have shown that PP2A Cα expression in both C3H10T1/2 and
3T3-L1 cells decreased in response to culturing in adipocyte differentia-
tion medium, leading to decreased PP2A activity. In contrast, the levels
of adipocyte differentiation markers such as PPARγ and C/EBPαincreased under these conditions. Several studies reported that insulin
down-regulated PP2A Cα expression and PP2A activity in muscle
[27–29], suggesting that insulin is mainly involved in the reduction of
PP2A Cα in C3H10T1/2 and 3T3-L1 in our experiment. These observa-
tions led us to hypothesize that PP2A Cα regulates adipocyte differenti-
ation by regulating the expression of adipocyte marker genes. To verify
our hypothesis, we constructed PP2A knockdown cells (shPP2A cells),
in which PP2A Cα expression was reduced constitutively. As expected,
PP2A Cα expression and its activity were signiﬁcantly lower in shPP2A
cells compared with that in shCont cells. There were no differences
in the cell proliferation rates of shCont and shPP2A cells (data not
shown). In the current study, we showed that the intensity of Oil red
O staining and triglyceride content was higher in shPP2A cells than
that in shCont cells, indicating that reduction of PP2A Cα strongly
enhanced adipocyte differentiation. The differentiation observed in
shPP2A cells was accompanied by a signiﬁcant increase in adipocyte
marker genes including PPARγ, C/EBPα, adiponectin, and FABP4.
These results indicate that PP2A Cα is a negative regulator of adipocyte
marker gene expression and that inhibition of PP2A leads to induction of
these adipocyte marker genes, which in turn accelerates adipocyte
differentiation.
TheWnt/GSK-3β/β-catenin pathway is also important for the deter-
mination of cell commitment in mesenchymal stem cells. Wnt10b, an
endogenous inhibitor of adipocyte differentiation, is highly expressed
in preadipocytes and declines rapidly after induction of adipocyte differ-
entiation [23,30,31]. Overexpression of Wnt10b in preadipocytes stabi-
lizes β-catenin and blocks adipogenesis. Moreover, the addition of
Wnt10b antisera to culture medium promotes adipocyte differentiation
[32]. Wnt signaling has also previously been shown to inhibit the
Fig. 10. Inhibition of PPARγ expression suppressed adipogenesis in shPP2A cells. shPP2A cells were transfected with a siRNA speciﬁc for PPARγ and then cultured in the adipocyte dif-
ferentiationmedium. Adipogenesis was assessed by Oil red O staining (A) and the triglyceride content of the cells wasmeasured (B) at day 7 after induction. Bar indicates 20 μm. Data are
mean ± SD of three separate experiments (**p b 0.01). (C), Total RNA was isolated and the mRNA expression of adipocyte marker genes was analyzed by real-time PCR and normalized
to Gapdh. Data are mean ± SD of three separate experiments (**p b 0.01).
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mesenchymal stem cells that are capable of differentiating into several
cell types including adipocytes and osteoblasts. Activation of the Wnt/
β-catenin pathway shifts the mesenchymal stem fate toward osteo-
blastogenesis at the expense of adipogenesis by suppressing C/EBPα
and PPARγ and increasing osteoblast speciﬁc transcription factors
[21]. As expected, in the present study, Wnt10b was signiﬁcantly
lower in shPP2A cells than that in shCont cells.
To examine the role of GSK-3β, we further performed aWestern blot
analysis using an antibody against phosphorylated GSK-3β, the inactive
form of GSK-3β. The levels of inactive form of GSK-3βwere remarkably
lower in shPP2A cells than those in shCont cells, implying that the ability
of GSK-3β to degrade β-catenin is higher in shPP2A cells. In accordance
with these results, β-catenin transcriptional activity decreased in
shPP2A cells in the present study. Moreover, not only the level of total
β-catenin but also the level of translocated nuclear β-catenin in
shPP2A cells was lower than those in shCont cells. PP2A can also directly
dephosphorylate and stabilize β-catenin [17,33]. Ablation of PP2A Cα
results in β-catenin redistribution to the cytoplasm where it is rapidly
degraded by the proteasome [7,34]. These reports support our present
results that β-catenin expression and its transcriptional activity were
reduced by PP2A Cα knockdown. Downregulation of β-catenin has
been reported to be coincident with increase in PPARγ in mesenchymal
progenitor cell lines and 3T3-L1 cells [35–37]. These observations
strongly suggest that GSK-3β is also a key regulator of accelerated
adipogenesis in shPP2A cells. Therefore, we examined the effect of
GSK-3β inhibition on the adipogenesis in shPP2A cells. Inhibition of
GSK-3β by LiCl treatment suppressed adipocyte marker gene expres-
sion and adipogenesis in shPP2A cells. These results are in accordance
with the previous studies that showed that inhibition of GSK-3β byLiCl inhibits adipocyte differentiation through the induction of active
β-catenin protein [35,36]. These ﬁndings suggest that the Wnt/GSK-
3β/β-catenin pathway under the control of PP2A is also involved in
adipogenesis.
Many factors regulate adipocyte differentiation during the forma-
tion of mature adipose tissue. Among them, PPARγ is known to be an
essential factor for adipocyte differentiation. Therefore, we examined
whether PPARγ regulated the expression of other adipocyte marker
genes in shPP2A cells, which in turn stimulate adipogenesis. Reduction
of PPARγ expression in shPP2A cells suppressed the expression of
C/EBPα, adiponectin, and FABP4. In addition, Reduction of PPARγ
expression suppressed the accelerated adipogenesis in shPP2A cells.
These results indicate that PPARγ is the most important target of
PP2A Cα and that PP2A Cα regulates adipogenesis by controlling
PPARγ expression.
We previously reported that PP2A Cα has important roles in osteo-
blast differentiation and functions by regulating the expression of
bone-related genes [38–40]. PP2A Cα levels decrease at an early stage
after induction of osteoblast differentiation. In this study, PP2A Cα was
also found to be downregulated during adipogenesis after the addition
of adipocyte differentiation medium. These observations suggest that
PP2A Cα has an inhibitory role in both osteoblastic and adipogenic
differentiation. Therefore, PP2A Cαmight respond to different stimuli
and play different roles in these two different differentiation pathways.
The multiple functions of PP2A Cαmight be facilitated by its interac-
tions with different binding partners in response to osteoblastic or
adipogenic stimulation. Further detailed studies are needed to deter-
mine how PP2A Cα controls the fate of mesenchymal cells including
adipocytes, osteoblasts, chondrocytes, and myoblasts under differ-
ent conditions.
2384 H. Okamura et al. / Biochimica et Biophysica Acta 1843 (2014) 2376–2384In summary, our present study showed that PP2ACα is an important
regulator of adipocyte differentiation by regulating the expression of
adipocyte marker genes and the Wnt10b/GSK-3β/β-catenin pathway.
PP2A Cα and PP2A activities were decreased during adipogenesis and
reduction of PP2A Cα expression accelerated adipogenesis through
the upregulation of adipocyte differentiation markers. The Wnt10b/
GSK-3β/β-catenin pathway was involved in PP2A Cα-mediated adipo-
genesis induction.
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